PNC Financial Services Group’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.28K | Buy |
529
+81
| +18% | +$655 | ﹤0.01% | 4192 |
|
|
2025
Q1 | $3.75K | Buy |
448
+13
| +3% | +$109 | ﹤0.01% | 4157 |
|
|
2024
Q4 | $3.45K | Sell |
435
-37
| -8% | -$293 | ﹤0.01% | 4142 |
|
|
2024
Q3 | $3.93K | Hold |
472
| – | – | ﹤0.01% | 4109 |
|
|
2024
Q2 | $3K | Sell |
472
-32
| -6% | -$203 | ﹤0.01% | 4141 |
|
|
2024
Q1 | $3.05K | Buy |
504
+274
| +119% | +$1.66K | ﹤0.01% | 4097 |
|
|
2023
Q4 | $1.4K | Buy |
230
+97
| +73% | +$589 | ﹤0.01% | 4255 |
|
|
2023
Q3 | $561 | Sell |
133
-200
| -60% | -$844 | ﹤0.01% | 4447 |
|
|
2023
Q2 | $1.03K | Buy |
333
+133
| +67% | +$412 | ﹤0.01% | 4504 |
|
|
2023
Q1 | $278 | Hold |
200
| – | – | ﹤0.01% | 4572 |
|
|
2022
Q4 | $398 | Hold |
200
| – | – | ﹤0.01% | 4561 |
|
|
2022
Q3 | $0 | Hold |
200
| – | – | ﹤0.01% | 4433 |
|
|
2022
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 4310 |
|
|
2022
Q1 | $1K | Hold |
200
| – | – | ﹤0.01% | 4300 |
|
|
2021
Q4 | $1K | Buy |
+200
| New | +$1K | ﹤0.01% | 4245 |
|
|
2020
Q4 | – | Sell |
-102
| Closed | – | – | 3953 |
|
|
2020
Q3 | $0 | Hold |
102
| – | – | ﹤0.01% | 3912 |
|
|
2020
Q2 | $0 | Hold |
102
| – | – | ﹤0.01% | 3899 |
|
|
2020
Q1 | $0 | Hold |
102
| – | – | ﹤0.01% | 3877 |
|
|
2019
Q4 | $0 | Hold |
102
| – | – | ﹤0.01% | 3971 |
|
|
2019
Q3 | $0 | Sell |
102
-219
| -68% | – | ﹤0.01% | 3978 |
|
|
2019
Q2 | $2K | Buy |
321
+154
| +92% | +$960 | ﹤0.01% | 3849 |
|
|
2019
Q1 | $3K | Buy |
167
+65
| +64% | +$1.17K | ﹤0.01% | 3820 |
|
|
2018
Q4 | $2K | Hold |
102
| – | – | ﹤0.01% | 3836 |
|
|
2018
Q3 | $2K | Sell |
102
-247
| -71% | -$4.84K | ﹤0.01% | 3932 |
|
|
2018
Q2 | $6K | Buy |
+349
| New | +$6K | ﹤0.01% | 3793 |
|